SEC Filing Summary

David Dieter, EVP & General Counsel of Collegium Pharmaceutical, Inc. (COLL), reported a disposition of 8,840 shares of Common Stock on March 17, 2026. The shares were disposed of at a price of $35.72 per share, resulting in a post-transaction ownership of 68,231 shares. The disposition was made to satisfy applicable withholding taxes upon the vesting of restricted stock units, as indicated by footnote F1. This transaction is classified as a disposition (code "D") under a Form 4 filing.